After years of sparring, the Biden administration and Gilead Sciences have settled a contentious lawsuit over patents for a ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Gilead Sciences (GILD) has reportedly settled a patent lawsuit with the federal government over its HIV drugs Truvada and ...

Biotech dealmaking is back — but smaller and more intimate. Deals disclosed in the early days of the new year indicate that ...

J&J, GSK, Eli Lilly and others struck high-value transactions in the early days of biopharma’s annual kickoff conference.

As the year gets underway, analysts and biotech executives highlight cell therapy’s pivot from oncology to autoimmune ...